News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,450 Results
Type
Article (89697)
Company Profile (664)
Press Release (808067)
Multimedia
Podcasts (284)
Webinars (44)
Section
Business (267525)
Career Advice (4177)
Deals (40167)
Drug Delivery (246)
Drug Development (92161)
Employer Resources (212)
FDA (18744)
Job Trends (17566)
News (399655)
Policy (40038)
Tag
2025 Best Places to Work (26)
2026 Best Places to Work (40)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (5)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2165)
Antibody-drug conjugate (ADC) (784)
Approvals (19345)
Artificial intelligence (1153)
ASCO (350)
Autoimmune disease (541)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (62)
Bladder cancer (253)
Brain cancer (105)
Breast cancer (986)
Cancer (8103)
Cardiovascular disease (689)
Career advice (3640)
Career pathing (65)
CAR-T (466)
CDC (82)
CDMO (239)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1286)
Cervical cancer (69)
Clinical research (81292)
Collaboration (2902)
Commercialization (77)
Company closure (10)
Compensation (1948)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (10)
C-suite (1719)
Cystic fibrosis (183)
Data (11232)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (209)
Diabetes (856)
Diagnostics (7956)
Digital health (88)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (570)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (104826)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142053)
Executive appointments (1386)
Eye disease (28)
FDA (23896)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2399)
Gene editing (323)
Generative AI (116)
Gene therapy (994)
GLP-1 (1419)
Government (5638)
Grass and pollen (8)
Guidances (446)
Healthcare (21528)
Hematology (239)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (433)
Immuno-oncology (166)
Indications (299)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (392)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2883)
JPM (73)
Kidney cancer (32)
Kidney disease (183)
Labor market (154)
Layoffs (734)
Leadership (70)
Legal (10180)
Licensing (137)
Liver cancer (121)
Longevity (58)
Lung cancer (1117)
Lung diease (27)
Lymphoma (571)
Machine learning (78)
Management (72)
Manufacturing (1668)
Marketing (43)
MASH (260)
Medical affairs (6)
Medical device (15491)
Medtech (15831)
Mergers & acquisitions (23658)
Metabolic disorders (2181)
Middle East (2)
mRNA (347)
Multiple sclerosis (264)
Multispecific (7)
NASH (24)
Netherlands (42)
Neurodegenerative disease (641)
Neuropsychiatric disorders (155)
Neuroscience (4392)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (103)
Obesity (1031)
Opinion (411)
Ovarian cancer (302)
Pain (354)
Pancreatic cancer (461)
Parkinson's disease (497)
Partnered (53)
Patents (820)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (122)
Peanut (81)
People (69190)
Peptides (46)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25071)
Phase 2 (35316)
Phase 3 (26616)
Pipeline (14775)
Policy (435)
Postmarket research (3561)
Preclinical (11219)
Press Release (74)
Prostate cancer (415)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (450)
Rare diseases (1622)
Real estate (7479)
Recruiting (84)
Regenerative medicine (40)
Regulatory (31942)
Reports (104)
Research institute (2824)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Series C (1)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4409)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (109)
Tax incentives (2)
The Weekly (169)
Vaccines (1455)
Venture capital (188)
Weight loss (686)
Wet AMD (8)
Women's health (191)
Women in leadership (2)
Worklife (28)
Date
Today (152)
Last 7 days (927)
Last 30 days (4103)
Last 365 days (34055)
2026 (31080)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51333)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1311)
Alabama (118)
Alaska (7)
Arizona (495)
Arkansas (17)
Asia (53227)
Australia (9374)
California (17428)
Canada (4793)
China (2075)
Colorado (776)
Connecticut (778)
Delaware (549)
Europe (122902)
Florida (2642)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1506)
India (158)
Indiana (787)
Iowa (37)
Japan (790)
Kansas (160)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2056)
Massachusetts (12615)
Michigan (477)
Minnesota (958)
Mississippi (8)
Missouri (191)
Montana (38)
Nebraska (31)
Nevada (208)
New Hampshire (94)
New Jersey (4614)
New Mexico (38)
New York (4542)
North Carolina (2253)
North Dakota (14)
Northern California (8903)
Ohio (544)
Oklahoma (32)
Oregon (55)
Pennsylvania (3339)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6950)
Tennessee (291)
Texas (2898)
United States (61778)
Utah (531)
Vermont (2)
Virginia (437)
Washington D.C. (90)
Washington State (1391)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,450 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Licensing
AbbVie grooves with DISCO’s solid tumor tech in up to $2.5B licensing deal
There’s a party going on at DISCO Pharma’s European headquarters after the precision medicine biotech signed its second major pharma partnership of the year—first Amgen, now AbbVie.
November 19, 2026
·
1 min read
·
Annalee Armstrong
Job Trends
Ramping up: 3 biotechs growing their workforce after series C raises
Biotechs that announced series C financing this year and are hiring include one that secured $140 million and has locations in London and Massachusetts.
November 19, 2026
·
4 min read
·
Angela Gabriel
Layoffs
9 biotechs will cut at least half their California workforces
Workforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with nine companies saying goodbye to at least half their staffs.
November 19, 2026
·
6 min read
·
Angela Gabriel
Press Releases
Emmaus Life Sciences Reports Quarterly Financial Results - November 18, 2026
November 18, 2026
·
6 min read
Press Releases
Harbour BioMed Announces NMPA Acceptance of IND Application for Its First AI-Enabled Drug Candidate LET003 for the Treatment of Overweight or Obesity
November 18, 2026
·
4 min read
Press Releases
FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis
November 18, 2026
·
5 min read
Press Releases
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
November 18, 2026
·
10 min read
Press Releases
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
November 18, 2026
·
7 min read
Press Releases
Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors
November 18, 2026
·
4 min read
Press Releases
Agilent Announces Cash Dividend of 26.25 Cents per Share
November 18, 2026
·
1 min read
1 of 89,845
Next